Home What we do Corporate and investor communications

Corporate and investor communications.

Our highly experienced Strategic Corporate and Financial Communications team works with innovative life sciences companies at all stages of growth and development. Together, we help you shape and amplify your corporate, scientific, and medical narratives to ensure that you reach relevant stakeholders across the globe, including media, investors, and corporates.

About us.

We bring significant and diverse life science sector experience and perspectives in corporate and financial communications, capital markets (sell-side research, investment banking, and asset management), media, and journalism. This invaluable experience is crucial to understanding your business and audiences and highlighting corporate value to support your core business objectives, from fundraising, partnering, profile raising, reputation management, recruitment, and more.

As a result, we have become trusted advisers to C-suite executives and Boards of Directors and built a client portfolio including some of the most innovative and exciting international life sciences and VC companies.

Our core capabilities.

Integrated communications advisory – strategy development, planning and execution

Equity story development – value proposition and presentation development

Corporate identity development – branding, website, corporate materials

Corporate PR solutions – media strategy and execution, including social media

Scientific and clinical development milestones – communicating complex data and information to stakeholders

Financial communications – financial reporting, analyst and investment banking relations, capital markets days

Transactions – private and public markets (including IPOs), partnering, M&A

Reputation management – shaping stakeholder perceptions and crisis communications

Advisers to over 100 companies over a
20+ year period.

+ IPOs

on 9 markets

raising >$3.5Bn

Secondary financings

raising >$3.5Bn

M&A transactions

with a total value of ~$18Bn

private financings

raising ~$2Bn

partnering transactions

with a total value of >$23Bn

VC financings

raising >$5Bn

Local team - global reach.

Based in London and Paris, our team is well-located to provide bespoke advice and execution to you while giving extensive reach and exposure to relevant global audiences through our network.

For clients seeking additional expertise for specific campaigns and on-the-ground support in the US and Asia, we give you access to additional strategic communications expertise through our network.

What differentiates us.

We are unique in that, as part of MEDiSTRAVA, we can support companies to create and deliver bespoke programs that optimize and align corporate and product narratives, providing compelling, differentiated, and evidence-based value propositions that help clients stand out from the competition.

These programs aim to maximize value and impact throughout the entire development journey, from start-up to commercialization, and can be readily scaled as needed.

We achieve this by curating highly complementary cross-functional teams of seasoned experts in communications and medical product development to fulfill your needs in the following areas:

  • Strategic corporate and financial communications
  • Scientific narrative development and publication strategy
  • Market analytics and competitive positioning, including target product profile development
  • Clinical trial design and optimization
  • Advisory board development and KOL engagement
  • Pricing evaluation, payor, and patient engagement

Latest thinking across MEDiSTRAVA.

We are thought leaders in the industry, driving the conversation and challenging our peers.

Read more about what our experts have to say.

Related solutions.

Contact us.

Learn more about MEDiSTRAVA’s strategic solutions and how we can help your business tackle the unique and evolving needs of leadership and Medical teams.